Clinical Trial Update: Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI) [Phase 3]

View source ↗

Summary

Phase 3 trial results comparing eptifibatide with abciximab during primary PCI for acute STEMI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• Abciximab (abciximab)
• EPTIFIBATIDE (EPTIFIBATIDE)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infarction, Myocardial | Phase 3 | Status: COMPLETED | Results posted: 2010-04-26